Loading...

Buy Full Version
"Opioids Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Opioids Market by Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone and Others) and Application (Pain Management, Cough Treatment, and Diarrhea): Global Opportunity Analysis and Industry Forecast, 2019-2026

LI_183556
Pages: 186
Oct 2019 | 2570 Views
 
Author(s) : Onkar Sumant & Kavita Joshi
Tables: 101
Charts: 40
 

Opioids Market Outlook - 2026

The global opioids market size was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026. Opioids are naturally occurring, synthetic or semi-synthetic compound that bind to opioid receptors and activate them. These receptors are present throughout the central nervous system of the human body and block the pain signals sent from the brain to the other parts of the body and release larger amounts of dopamine in the body. Opioids reduce the intensity of pain and are generally safe when taken as prescribed by the healthcare professional for shorter duration. Opioids are majorly used to treat pain associated with rheumatic diseases, cancer, anxiety or sleep disorders, and severe pain related to coughing & diarrhea. Since opioids effectively relieves chronic pain, the risk of addiction is high in the individuals. Although opioids serve as a cost-effective solution for patients suffering from low back pain, cancer pain, and others, its addictive nature has led to drug misuse. Opioid consumption can have major side effects including confusion, drowsiness, constipation, nausea, slowed breathing, and euphoria. 

Opioids Market

Get more information on this report : Request Sample Pages

The global opioids market growth is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for opioids market expansion in the near future.

Opioids Market
By Product

Your browser does not support the canvas element.

Fentanyl is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Global Opioids Market Segmentation

The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the opioids market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Opioids Market
By Application

Your browser does not support the canvas element.

Pain Management is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Segment review

Based on product type, the opioid market is divided into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The oxycodone segment held a major share in the opioids market in 2018 and is expected to continue the trend during the forecast period. This is attributed to increase in consumption for pain management. The fentanyl segment is anticipated to be the fastest growing segment owing to its availability in multiple formulations including solutions for injection in multiple concentrations for acute pain management and anesthesia, and as oral tablets & lozenges, transdermal patches, and nasal sprays for treating of chronic pain. Thus, the availability and increase in usage of fentanyl in drugs for pain management is expected to provide lucrative opportunities for market expansion.

According to the global opioids market analysis, the application segment is classified into pain management, cough treatment, and diarrhea treatment. Under the pain management segment, the market is further divided into neuropathic pain, migraine, back pain, osteoarthritis pain, and cancer pain. The pain management segment dominated the global opioid market in 2018 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to wide usage of opioids for pain management ranging from mild to severe pain across the globe. Different types of opioids are used to treat various pain. 

The report provides an extensive competitive analysis and profiles of the key opioids market players such as Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Allergan, Plc, and Pfizer, Inc. 

Opioids Market
By Region

2026
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific region would exhibit the highest CAGR of 3.0% during 2018-2026.

Get more information on this report : Request Sample Pages

Key Benefits for Opioids Market:

  • The opioids market share and analysis is based on a comprehensive analysis of key developments in the opioids industry.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market and current & future trends to elucidate the imminent investment pockets.
  • The global opioids market trends are studied from 2018 to 2026
  • Information about key drivers, restrains, and opportunities and their impact analysis on the opioids market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global opioids market from 2019 to 2026 is provided to determine the market potential.

Opioids Market Segments:

By Product Type

  • Codeine 
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

By Application

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment

By Region 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific 
    • China
    • Japan
    • India
    • Australis
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Research methodology

1.3.1.    Secondary research
1.3.2.    Primary research
1.3.3.    Analyst tools & models

CHAPTER 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

CHAPTER 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Porter's five forces analysis
3.3.    Top player positioning
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Increase use of opioids in pain management
3.4.1.2.    Upsurge in consumption of opioids in developing economies

3.4.2.    Restraints

3.4.2.1.    Implementation of stringent government regulation toward vigorous prescription
3.4.2.2.    Opioid crisis across the globe

3.4.3.    Impacting factors

CHAPTER 4:    OPIOIDS MARKET, BY PRODUCT

4.1.    Overview

4.1.1.    Market size and forecast, by product type

4.2.    Codeine

4.2.1.    Key market trends
4.2.2.    Market size and forecast, by region
4.2.3.    Market analysis, by country

4.3.    Fentanyl

4.3.1.    Key market trends
4.3.2.    Market size and forecast, by region
4.3.3.    Market analysis, by country

4.4.    Oxycodone

4.4.1.    Key market trends
4.4.2.    Market size and forecast, by region
4.4.3.    Market analysis, by country

4.5.    Methadone

4.5.1.    Key market trends
4.5.2.    Market size and forecast
4.5.3.    Market analysis, by country

4.6.    Morphine

4.6.1.    Key market trends
4.6.2.    Market size and forecast
4.6.3.    Market analysis, by country

4.7.    Hydrocodone

4.7.1.    Key market trends
4.7.2.    Market size and forecast
4.7.3.    Market analysis, by country

4.8.    Others

4.8.1.    Key market trends
4.8.2.    Market size and forecast
4.8.3.    Market analysis, by country

CHAPTER 5:    OPIOIDS MARKET, BY APPLICATION

5.1.    Overview

5.1.1.    Market size and forecast, by application

5.2.    Pain management

5.2.1.    Market size and forecast, by region
5.2.2.    Market analysis, by country

5.2.2.1.    Neuropathic pain

5.2.2.1.1.    Market size and forecast

5.2.2.2.    Migraine

5.2.2.2.1.    Market size and forecast

5.2.2.3.    Back pain

5.2.2.3.1.    Market size and forecast

5.2.2.4.    Osteoarthritis pain

5.2.2.4.1.    Market size and forecast

5.2.2.5.    Cancer pain

5.2.2.5.1.    Market size and forecast

5.2.2.6.    Others

5.2.2.6.1.    Market size and forecast

5.3.    Cough treatment

5.3.1.    Market size and forecast, by region
5.3.2.    Market analysis, by country

5.4.    Diarrhea treatment

5.4.1.    Market size and forecast, by region
5.4.2.    Market analysis, by country

CHAPTER 6:    OPIOIDS MARKET, BY REGION

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    North America

6.2.1.    Key market trends
6.2.2.    Market size and forecast, by product
6.2.3.    Market size and forecast, by application
6.2.4.    Market size and forecast, by country

6.2.4.1.    U.S. market size and forecast, by product
6.2.4.2.    U.S. market size and forecast, by application
6.2.4.3.    Canada market size and forecast, by product
6.2.4.4.    Canada market size and forecast, by application
6.2.4.5.    Mexico market size and forecast, by product
6.2.4.6.    Mexico market size and forecast, by application

6.3.    Europe

6.3.1.    Key market trends
6.3.2.    Market size and forecast, by product
6.3.3.    Market size and forecast, by application
6.3.4.    Market size and forecast, by country

6.3.4.1.    France market size and forecast, by product
6.3.4.2.    France market size and forecast, by application
6.3.4.3.    UK market size and forecast, by product
6.3.4.4.    UK market size and forecast, by application
6.3.4.5.    Germany market size and forecast, by product
6.3.4.6.    Germany market size and forecast, by application
6.3.4.7.    Spain market size and forecast, by product
6.3.4.8.    Spain market size and forecast, by application
6.3.4.9.    Rest of Europe market size and forecast, by product
6.3.4.10.    Rest of Europe market size and forecast, by application

6.4.    Asia-Pacific

6.4.1.    Key market trends
6.4.2.    Market size and forecast, by product
6.4.3.    Market size and forecast, by application
6.4.4.    Market size and forecast, by country

6.4.4.1.    Japan market size and forecast, by product
6.4.4.2.    Japan market size and forecast, by application
6.4.4.3.    China market size and forecast, by product
6.4.4.4.    China market size and forecast, by application
6.4.4.5.    India market size and forecast, by product
6.4.4.6.    India market size and forecast, by application
6.4.4.7.    Australia market size and forecast, by product
6.4.4.8.    Australia market size and forecast, by application
6.4.4.9.    Taiwan market size and forecast, by product
6.4.4.10.    Taiwan market size and forecast, by application
6.4.4.11.    South Korea market size and forecast, by product
6.4.4.12.    South Korea market size and forecast, by application
6.4.4.13.    Rest of Asia-Pacific market size and forecast, by product
6.4.4.14.    Rest of Asia-Pacific market size and forecast, by application

6.5.    LAMEA

6.5.1.    Key market trends
6.5.2.    Market size and forecast, by product
6.5.3.    Market size and forecast, by application
6.5.4.    Market size and forecast, by country

6.5.4.1.    Brazil market size and forecast, by product
6.5.4.2.    Brazil market size and forecast, by application
6.5.4.3.    Turkey market size and forecast, by product
6.5.4.4.    Turkey market size and forecast, by application
6.5.4.5.    Saudi Arabia market size and forecast, by product
6.5.4.6.    Saudi Arabia market size and forecast, by application
6.5.4.7.    South Africa market size and forecast, by product
6.5.4.8.    South Africa market size and forecast, by application
6.5.4.9.    Rest of LAMEA market size and forecast, by product
6.5.4.10.    Rest of LAMEA market size and forecast, by application

CHAPTER 7:    COMPONY PROFILES

7.1.    ALLERGAN PLC.

7.1.1.    Company overview
7.1.2.    Company snapshot
7.1.3.    Operating business segments
7.1.4.    Product portfolio
7.1.5.    Business performance

7.2.    BOEHRINGER INGELHEIM GROUP

7.2.1.    Company overview
7.2.2.    Company snapshot
7.2.3.    Operating business segments
7.2.4.    Product portfolio
7.2.5.    Business performance

7.3.    ENDO PHARMACEUTICALS INC. (PAR PHARMACEUTICAL)

7.3.1.    Company overview
7.3.2.    Company snapshot
7.3.3.    Operating business segments
7.3.4.    Product portfolio
7.3.5.    Business performance

7.4.    JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC)

7.4.1.    Company overview
7.4.2.    Company snapshot
7.4.3.    Operating business segments
7.4.4.    Product portfolio
7.4.5.    Business performance

7.5.    MALLINCKRODT PLC (SPECGX LLC)

7.5.1.    Company overview
7.5.2.    Company snapshot
7.5.3.    Operating business segments
7.5.4.    Product portfolio
7.5.5.    Business performance

7.6.    PFIZER INC.

7.6.1.    Company overview
7.6.2.    Company snapshot
7.6.3.    Operating business segments
7.6.4.    Product portfolio
7.6.5.    Business performance

7.7.    PURDUE PHARMA L.P.

7.7.1.    Company overview
7.7.2.    Company snapshot
7.7.3.    Operating business segments
7.7.4.    Product portfolio
7.7.5.    Business performance

7.8.    SANOFI S.A.

7.8.1.    Company overview
7.8.2.    Company snapshot
7.8.3.    Operating business segments
7.8.4.    Product portfolio
7.8.5.    Business performance

7.9.    SUN PHARMACEUTICAL INDUSTRIES LTD.

7.9.1.    Company overview
7.9.2.    Company snapshot
7.9.3.    Operating business segments
7.9.4.    Product portfolio
7.9.5.    Business performance

7.10.    TEVA PHARMACEUTICAL INDUSTRIES LIMITED

7.10.1.    Company overview
7.10.2.    Company snapshot
7.10.3.    Operating business segments
7.10.4.    Product portfolio
7.10.5.    Business performance

LIST OF TABLES

TABLE 01.    GLOBAL OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02.    CODEINE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03.    CODEINE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 04.    FENTANYL MARKET BY REGION 2018–2026 ($MILLION)
TABLE 05.    FENTANYL MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 06.    OXYCODONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07.    OXYCODONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 08.    METHADONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 09.    METHADONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 10.    MORPHINE MARKET BY REGION, 2018–2026 ($MILLION)
TABLE 11.    MORPHINE MARKET BY COUNTRY, 2018–2026 ($MILLION)
TABLE 12.    HYDROCODONE MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 13.    HYDROCODONE MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 14.    OTHER OPIOID DRUGS MARKET BY REGION, 2018–2026 ($MILLION)
TABLE 15.    OTHER OPIOID DRUGS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 16.    GLOBAL OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 17.    OPIOIDS MARKET FOR PAIN MANAGEMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 18.    OPIOIDS MARKET FOR COUGH TREATMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 19.    OPIOIDS MARKET FOR DIARRHEA TREATMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 20.    OPIOIDS MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 21.    NORTH AMERICA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 22.    NORTH AMERICA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 23.    NORTH AMERICA OPIOIDS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 24.    U.S. OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 25.    U.S. OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 26.    CANADA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 27.    CANADA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 28.    MEXICO OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 29.    MEXICO OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 30.    EUROPE OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31.    EUROPE OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 32.    EUROPE OPIOIDS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 33.    FRANCE OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 34.    FRANCE OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 35.    UK OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 36.    UK OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 37.    GERMANY OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 38.    GERMANY OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 39.    SPAIN OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40.    SPAIN OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 41.    REST OF EUROPE OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 42.    REST OF EUROPE OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 43.    ASIA-PACIFIC OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 44.    ASIA-PACIFIC OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 45.    ASIA-PACIFIC OPIOIDS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46.    JAPAN OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 47.    JAPAN OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 48.    CHINA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 49.    CHINA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 50.    INDIA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 51.    INDIA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 52.    AUSTRALIA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53.    AUSTRALIA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 54.    TAIWAN OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 55.    TAIWAN OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 56.    SOUTH KOREA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 57.    SOUTH KOREA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 58.    REST OF ASIA-PACIFIC OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 59.    REST OF ASIA-PACIFIC OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 60.    LAMEA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 61.    LAMEA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 62.    LAMEA OPIOIDS MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 63.    BRAZIL OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 64.    BRAZIL OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 65.    TURKEY OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 66.    TURKEY OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 67.    SAUDI ARABIA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 68.    SAUDI ARABIA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 69.    SOUTH AFRICA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 70.    SOUTH AFRICA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 71.    REST OF LAMEA OPIOIDS MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 72.    REST OF LAMEA OPIOIDS MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 73.    ALLERGAN: COMPANY SNAPSHOT
TABLE 74.    ALLERGAN: OPERATING SEGMENTS
TABLE 75.    ALLERGAN: PRODUCT PORTFOLIO
TABLE 76.    BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 77.    BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 78.    BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 79.    ENDO: COMPANY SNAPSHOT
TABLE 80.    ENDO: OPERATING SEGMENTS
TABLE 81.    ENDO: PRODUCT PORTFOLIO
TABLE 82.    J&J: COMPANY SNAPSHOT
TABLE 83.    J&J: OPERATING SEGMENTS
TABLE 84.    J&J: PRODUCT TYPE PORTFOLIO
TABLE 85.    MALLINCKRODT: COMPANY SNAPSHOT
TABLE 86.    MALLINCKRODT: OPERATING SEGMENTS
TABLE 87.    MALLINCKRODT: PRODUCT PORTFOLIO
TABLE 88.    PFIZER: COMPANY SNAPSHOT
TABLE 89.    PFIZER: OPERATING SEGMENTS
TABLE 90.    PFIZER: PRODUCT PORTFOLIO
TABLE 91.    PURDUE: COMPANY SNAPSHOT
TABLE 92.    PURDUE: PRODUCT PORTFOLIO
TABLE 93.    SANOFI: COMPANY SNAPSHOT
TABLE 94.    SANOFI: OPERATING SEGMENTS
TABLE 95.    SANOFI: PRODUCT PORTFOLIO
TABLE 96.    SUN PHARMA: COMPANY SNAPSHOT
TABLE 97.    SUN PHARMA: OPERATING SEGMENTS
TABLE 98.    SUN PHARMA: PRODUCT PORTFOLIO
TABLE 99.    TEVA: COMPANY SNAPSHOT
TABLE 100.    TEVA: OPERATING SEGMENTS
TABLE 101.    TEVA: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    GLOBAL OPIOID MARKET SEGMENTATION
FIGURE 02.    LOW-TO- MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03.    LOW BARGAINING POWER OF BUYER
FIGURE 04.    MODERATE THREAT OF SUBSTITUTES
FIGURE 05.    LOW-TO-MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.    HIGH COMPETITIVE RIVALARY
FIGURE 07.    TOP PLAYER POSITIONING, 2018
FIGURE 08.    DRIVERS AND RESTRAINTS
FIGURE 09.    COMPARATIVE SHARE ANALYSIS OF OPIOIDS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.    GLOBAL OPIOIDS MARKET FOR NEUROPATHIC PAIN, 2018–2026 ($MILLION)
FIGURE 11.    GLOBAL OPIOIDS MARKET FOR MIGRAINE, 2018–2026 ($MILLION)
FIGURE 12.    GLOBAL OPIOIDS MARKET FOR BACK PAIN, 2018–2026 ($MILLION)
FIGURE 13.    GLOBAL OPIOIDS MARKER FOR OSTEOARTHRITIS, 2018–2026 ($MILLION)
FIGURE 14.    GLOBAL OPIOIDS MARKER FOR CANCER PAIN, 2018–2026 ($MILLION)
FIGURE 15.    GLOBAL OPIOIDS MARKER FOR OTHER APLLICATIONS, 2018–2026 ($MILLION)
FIGURE 16.    COMPARATIVE SHARE ANALYSIS OF OPIOIDS MARKET FOR COUGH TREATMENT, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.    COMPARATIVE SHARE ANALYSIS OF OPIOIDS MARKET FOR DIARRHEA TREATMENT, BY COUNTRY,  2018 & 2026 (%)
FIGURE 18.    ALLERGAN: NET SALES, 2016–2018 ($MILLION)
FIGURE 19.    ALLERGAN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 20.    BOEHRINGER INGELHEIM: NET SALES, 2016–2018 ($MILLION)
FIGURE 21.    BOEHRINGER INGELHEIM: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 22.    BOEHRINGER INGELHEIM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 23.    ENDO: NET SALES, 2016–2018 ($MILLION)
FIGURE 24.    ENDO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 25.    J&J: REVENUE, 2016–2018 ($MILLION)
FIGURE 26.    J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27.    J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28.    MALLINCKRODT: NET SALES, 2016–2018 ($MILLION)
FIGURE 29.    MALLINCKRODT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30.    MALLINCKRODT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31.    PFIZER: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.    PFIZER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33.    PFIZER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34.    SANOFI: NET SALES, 2016–2018 ($MILLION)
FIGURE 35.    SANOFI: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36.    SANOFI: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37.    SUN PHARMA: NET SALES, 2016–2018 ($MILLION)
FIGURE 38.    SUN PHARMA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39.    TEVA: NET SALES, 2016–2018 ($MILLION)
FIGURE 40.    TEVA: REVENUE SHARE BY SEGMENT, 2018 (%)

 
 

Opioids are often referred to as narcotics and help in combating pain; however, they do not fall into the over-the-counter category of painkillers, such as aspirin and tylenol. The most commonly prescribed opioids include oxycontin, vicodin, and fentanyl. The opioid market is anticipated to witness slow growth in future owing to the opioid crisis across the globe. However, rise in prevalence of orthopedic diseases due to sedentary lifestyle, upsurge in geriatric population, and increase in consumption of opioids for pain management ranging from moderate to severe pain are anticipated to drive its market growth. However, consistent use of these prescribed drugs can increase person’s tolerance and addiction, requiring higher and more frequent doses, leading to opioid addiction. Thus, increase in opioid addiction and side effects has limited their use, thereby, restraining the growth of the market. The misuse and addiction to opioids, including prescription pain relievers, heroin, and synthetic opioids such as fentanyl, hydrocodone is a serious global crisis that has affected public health as well as social and economic welfare, which has further hampered the market growth. Although opioids are vigorously used for pain management, the market is experiencing slow growth, owing to increase in deaths due to opioid overdose/misuse.

In addition, North America accounted for the majority of market share in 2018 and is anticipated to continue this trend during the forecast period. This is attributed to vigorous use and ease of availability of opioid analgesics in this region. However, Asia-Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of key players such as Teva Pharmaceuticals, Janssen Pharmaceuticals, Inc., and others in the region. 
 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Download Sample

Request Customization

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The market vaule of global Opioid market was $18,532.8 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global opioids market in 2019 is $19,007.2 million.

A. The opioid market is anticipated to witness steady growth in future, owing to rise in prevalence of orthopedic diseases due to sedentary lifestyle, and increase in consumption of opioids for pain management.

A. The segments are growing at a slower growth rate owing the opiod crisis and increased deaths due to over consumption of opiods.

A. Increased usage of opioid drugs as analgesics across the globe is the major key trend.

A. Emerging countries of Asia-Pacific region are growing at a growth% of 3.0%. India, China, Australia, South Korea are expected grow at a CAGR of 5.5%, 4.4%, 3.1%, 2.7% respectively.

A. The oxycodone segment held a major share in the opioids market in 2018 and is expected to continue the trend in the forecasting period. This is attributed to increase in its consumption for pain management.

image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Opioids Market

  • Online Only
  • $3,456  $3,041
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,379
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370  $4,296
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $4,838
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $6,297
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample